Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ifrah

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Blood|November 5, 2020
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALLMathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, et al.
BMC Medical Genomics|February 1, 2012
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samplesDiane Raingeard de la Blétière, Odile Blanchet, Pascale Cornillet-Lefèbvre, et al.
Blood|May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyJean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
Journal of Hematology & Oncology|January 20, 2017
Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Xavier Poiré, Myriam Labopin, Johan Maertens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL studyAline Tanguy-Schmidt, Philippe Rousselot, Yves Chalandon, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Blood|October 7, 2011
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemiaBob Löwenberg, Petra Muus, Gert Ossenkoppele, et al.
Blood Advances|July 5, 2019
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemiaMarion Alcantara, Mathieu Simonin, Ludovic Lhermitte, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Blood|November 5, 2020
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALLMathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, et al.
BMC Medical Genomics|February 1, 2012
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samplesDiane Raingeard de la Blétière, Odile Blanchet, Pascale Cornillet-Lefèbvre, et al.
Blood|May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyJean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
Journal of Hematology & Oncology|January 20, 2017
Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Xavier Poiré, Myriam Labopin, Johan Maertens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL studyAline Tanguy-Schmidt, Philippe Rousselot, Yves Chalandon, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Blood|October 7, 2011
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemiaBob Löwenberg, Petra Muus, Gert Ossenkoppele, et al.
Blood Advances|July 5, 2019
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemiaMarion Alcantara, Mathieu Simonin, Ludovic Lhermitte, et al.
Pageof 17